Company / Accounts Receivable
CorMedix Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$171.2M
FY2025
5-year range
$45.4K / $171.2M
FY2021-FY2025
Trend
+231.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable changed +231% YoY in FY2025, a notable deviation from the 6-year average annual change of +20844%.
Based on SEC 10-K filings.
$171M in FY2025 with a 5-year CAGR of +774.0%.
Improved from $45,368 to $171M over the past 4 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +774.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +774.0%, indicating consistent growth.
- In FY2025, accounts receivable increased 231.5% year-over-year.
- Lowest accounts receivable in the period was in FY2019.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $171.2M | +231.5% |
| FY2024 | $51.7M | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $45.4K | +1251.4% |
| FY2020 | $3.4K | +9491.4% |
| FY2019 | $35 | - |
| FY2018 | - | - |
| FY2017 | $64.1K | +433.9% |
| FY2016 | $12.0K | -96.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026